FY2017 Earnings Estimate for UnitedHealth Group Incorporated (UNH) Issued By Jefferies Group

UnitedHealth Group Incorporated (NYSE:UNH) – Investment analysts at Jefferies Group lifted their FY2017 earnings estimates for shares of UnitedHealth Group in a research note issued on Tuesday. Jefferies Group analyst D. Windley now forecasts that the healthcare conglomerate will earn $10.00 per share for the year, up from their previous estimate of $9.88. Jefferies Group currently has a “Buy” rating and a $225.00 target price on the stock. Jefferies Group also issued estimates for UnitedHealth Group’s Q4 2017 earnings at $2.51 EPS, Q1 2018 earnings at $2.68 EPS, Q2 2018 earnings at $2.67 EPS, Q3 2018 earnings at $2.88 EPS, Q4 2018 earnings at $2.63 EPS, FY2018 earnings at $10.86 EPS and FY2019 earnings at $12.42 EPS.

UNH has been the topic of several other reports. Barclays PLC lifted their target price on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. Leerink Swann reaffirmed a “buy” rating and set a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a report on Thursday, September 21st. Cowen and Company reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 14th. Finally, Oppenheimer Holdings, Inc. lifted their target price on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $215.27.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2017/10/29/fy2017-earnings-estimate-for-unitedhealth-group-incorporated-unh-issued-by-jefferies-group.html.

UnitedHealth Group (UNH) opened at 203.25 on Thursday. The stock’s 50 day moving average price is $197.17 and its 200-day moving average price is $185.63. The firm has a market capitalization of $201.01 billion, a price-to-earnings ratio of 23.08 and a beta of 0.63. UnitedHealth Group has a one year low of $133.03 and a one year high of $207.80.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company earned $2.17 earnings per share.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock valued at $14,981,909 over the last ninety days. 0.89% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of UNH. Harbour Capital Advisors LLC increased its holdings in UnitedHealth Group by 18,383.4% during the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after purchasing an additional 2,503,090 shares in the last quarter. Janus Henderson Group PLC increased its holdings in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. Parametric Portfolio Associates LLC increased its holdings in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after purchasing an additional 1,562,661 shares in the last quarter. Finally, Jennison Associates LLC increased its holdings in UnitedHealth Group by 180.4% during the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after purchasing an additional 1,449,130 shares in the last quarter. 86.11% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply